Aortic Aneurysm, Thoracic, Aortic Diseases, Cardiopulmonary Arrest, Coronary Artery Disease
Conditions
Keywords
aortic diseases, aortic aneurysm, electroencephalography, Near-Infrared spectroscopy, Transcranial Doppler ultrasonography, Cardiopulmonary arrest, Hypothermia, Induced
Brief summary
The aim of this prospective, explorative study of noninvasive neuromonitoring was to search potential and practical methods associated with neurological outcome in the perioperative and immediate postoperative setting of surgery of the thoracic aorta. These methods include abbreviated EEG monitoring, near-infrared spectroscopy, transcranial Doppler ultrasound and biochemical markers associated with neuronal damage.
Detailed description
For the purpose of this study, 30 patients undergoing aortic surgery via a median sternotomy (n=29; 97%) or left thoracotomy (n=1; 3%) and cardiopulmonary bypass with deep hypothermic cardiac arrest were recruited. All patients were operated under deep hypothermia and circulatory arrest, with optional selective cerebral perfusion during circulatory arrest. Active patient recruitment started from September 2007 and ended in May 2011. All patients were monitored with a bilateral fronto-temporal four channel abbreviated EEG, a bilateral frontal two-channel near-infrared spectroscopy, postoperative transcranial Doppler ultrasound evaluation of median artery circulation and postoperative biochemical neuromarkers. The study montage was set up by a dedicated research nurse, who also performed the transcranial Doppler measurements. The neuromonitoring data were not used at the time to guide therapeutic decisions, with the exception of near-infrared spectroscopy monitoring.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients scheduled for elective or emergency surgery on the thoracic aorta (study group) or coronary heart disease (control groups) * Informed consent from patient or next of kin
Exclusion criteria
* Age under 18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Neurological outcome | Monitoring period from anesthesia induction to 48 hours after end of surgery | Permanent neurological damage or death within monitoring period (up to 48 h after surgery) |
Countries
Finland